Curis Inc (CRIS)

Curis Inc (CRIS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $981,914; returns 1 day -4.6%, 1 week -5.1%, 1 year -98.8%.

Curis Inc. is a clinical-stage biotechnology company primarily focused on the development of novel targeted small molecule therapeutics for the treatment of human cancers, with a particular emphasis on hematologic malignancies and solid tumors.

Groups CRIS belongs to

• Biotechnology
• Recent Reverse Splits
• Clinical Stage Biotech
• Oncology
• Clinical Stage
• Hematologic Malignancies
• Cancer Therapeutics
• Healthcare
• Biopharmaceutical

CRIS financial model: income statement, cash flow and balance sheet